Clinical Practice & Guidelines Flashcards
7 cards from real DHA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Clinical Practice & Guidelines flashcards as text
A 65-year-old male with COPD has an FEV1/FVC ratio of 0.62 and FEV1 of 55% predicted. Per DHA/GOLD guidelines, what GOLD stage is this?
Answer: GOLD 2 (Moderate)
GOLD Stage 2 (Moderate COPD) is defined by FEV1/FVC <0.70 with FEV1 50–79% predicted.
Under DHA guidelines for pain management, which WHO analgesic ladder step is appropriate for a patient with moderate cancer pain (NRS 5/10) who has failed Step 1 therapy?
Answer: Step 2: Weak opioids (e.g., codeine or tramadol)
The WHO analgesic ladder prescribes Step 2 weak opioids (tramadol, codeine) for moderate pain when non-opioids (Step 1) are insufficient.
Per DHA infection control guidelines, which PPE combination is required when performing an aerosol-generating procedure (AGP) on a patient with suspected airborne infection?
Answer: N95 respirator, gloves, gown, and eye protection
AGPs on suspected airborne-infection patients require N95 (or equivalent) respirator, gloves, fluid-resistant gown, and eye/face protection per DHA infection control standards.
A child is brought to the DHA clinic with a weight-for-height Z-score of -2.8. How should this nutritional status be classified per WHO/DHA standards?
Answer: Moderate acute malnutrition
A weight-for-height Z-score between -3 and -2 (exclusive) indicates Moderate Acute Malnutrition (MAM) requiring therapeutic nutritional support.
According to DHA guidelines, what is the target LDL-cholesterol level for a patient classified as very high cardiovascular risk (e.g., prior MI)?
Answer: < 1.8 mmol/L (< 70 mg/dL)
For very high CV risk patients including those with prior MI, the LDL target is <1.8 mmol/L (<70 mg/dL) with ≥50% reduction from baseline per DHA/ESC guidelines.
Under DHA clinical governance standards, a 'never event' occurs in the hospital. What is the mandatory initial reporting timeframe to the DHA?
Answer: Within 24 hours
DHA patient safety regulations require that never events and serious adverse events be reported to the DHA within 24 hours of discovery.
A patient on warfarin presents with an INR of 7.2 and minor bleeding (gum bleeding). Per DHA anticoagulation guidelines, what is the most appropriate management?
Answer: Hold warfarin, give oral vitamin K 1–2.5mg, and monitor INR
For supratherapeutic INR (>5) with minor bleeding, holding warfarin and administering low-dose oral vitamin K (1–2.5mg) is recommended, with INR recheck within 24–48 hours.